Estrogen receptor pathway: resistance to endocrine therapy and new therapeutic approaches.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16914563.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Endocrine therapy is widely accepted as the most important treatment for all patients with hormone receptor-positive breast cancer. However, despite the positive effect of endocrine therapy on clinical outcome, resistance to these drugs inevitably develops. This article reviews the problem of resistance to hormonal therapy and addresses potential approaches to overcome intrinsic or acquired mechanisms of resistance.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Breast Neoplasms
- Receptors, Estrogen